Molecular imaging is an essential component for the early detection and diagnosis of many types of cancer, including ovarian, cervical, lung and prostate cancer. Using state-of-the-art equipment and precisely targeted tracers, molecular imaging enables physicians to see how disease functions within the body.

To register or learn more information about the meeting or submission process, please visit http://www.astro.org/Meetings/UpcomingMeetings/Translational/index.asp.


About SNM-Advancing Molecular Imaging and Therapy
SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.

SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.

Back to HCB News

More Industry Headlines